Leslie Z. Benet - Concepedia

Author

Leslie Z. Benet

University of California, San Francisco ORCID

Also Known As

Dr. Leslie Z. Benet, L BENET, L Z Benet, L. Benet, L. Z. BENET, L. Z. Benet, L.Z Benet, L.Z. BENET, L.Z. Benet, LESLIE Z BENET

629

Publications

37.6K

Citations

H-Index

200

Concepts

All Affiliations

University of California, San Francisco University of California System NGM Biopharmaceuticals (United States)

About

Leslie Z. Benet is an author at University of California, San Francisco specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	51	172	10.1K
2	Health Sciences	15	18	955
3	Natural Sciences	15	16	999
4	Engineering	8	8	885
5	Education	1	1	11

Leslie Z. Benet

353

Publications

21.4K

Citations

H-Index

Page 1

	Year	Citations
Clearance concepts in pharmacokinetics Malcolm Rowland, Leslie Z. Benet, Garry G. Graham Journal of Pharmacokinetics and Biopharmaceutics Therapeutic Drug MonitoringPharmacodynamicsMedicineClearance ConceptsPharmacology	1973	761
Noncompartmental Determination of the Steady‐State Volume of Distribution Leslie Z. Benet, Renato L. Galeazzi Journal of Pharmaceutical Sciences Mixture DistributionEngineeringDensity EstimationMeasurementNumerical Simulation	1979	737
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine* Kenneth S. Lown, Robert R. Mayo, Alan B. Leichtman, Clinical Pharmacology & Therapeutics	1997	683
BDDCS Applied to Over 900 Drugs Leslie Z. Benet, Fabio Broccatelli, Tudor I. Oprea The AAPS Journal MedicineBddcs AppliedPharmacotherapyDrug DevelopmentPharmacology	2011	613
Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine* Chi-Yuan Wu, Leslie Z. Benet, Mary F. Hébert, Clinical Pharmacology & Therapeutics Cyclosporine AbsorptionGastrointestinal PharmacologyGastroenterologyDigestive TractGut-organ Axis	1995	355
Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction Mary F. Hébert, John P. Roberts, Thomayant Prueksaritanont, Clinical Pharmacology & Therapeutics	1992	338
Effect of OATP1B Transporter Inhibition on the Pharmacokinetics of Atorvastatin in Healthy Volunteers Yvonne Lau, Yong Huang, Lynda Frassetto, Clinical Pharmacology & Therapeutics	2006	324
Active secretion and enterocytic drug metabolism barriers to drug absorption Vincent J. Wacher, Laurent Salphati, Leslie Z. Benet Advanced Drug Delivery Reviews Pharmacological StudyBiochemistryMedicinePhysiologyActive Secretion	1996	310
Identification of the Hepatic Protein Targets of Reactive Metabolites of Acetaminophen in Vivoin Mice Using Two-dimensional Gel Electrophoresis and Mass Spectrometry Yongchang Qiu, Leslie Z. Benet, Alma L. Burlingame Journal of Biological Chemistry Drug TargetMetabolomic ProfilingPharmacological StudyBioanalysisToxicology	1998	298
Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery Leslie Z. Benet, Takashi Izumi, Yuanchao Zhang, Journal of Controlled Release BiochemistryP-450 EnzymesGastrointestinal PharmacologyMedicineOral Drug Delivery	1999	294

Page 1